Advances in chitosan and chitosan derivatives for biomedical applications in tissue engineering: An updated review

Int J Biol Macromol. 2024 Mar;262(Pt 1):129999. doi: 10.1016/j.ijbiomac.2024.129999. Epub 2024 Feb 7.

Abstract

In recent years, chitosan (CS) has received much attention as a functional biopolymer for various applications, especially in the biomedical field. It is a natural polysaccharide created by the chemical deacetylation of chitin (CT) that is nontoxic, biocompatible, and biodegradable. This natural polymer is difficult to process; however, chemical modification of the CS backbone allows improved use of functional derivatives. CS and its derivatives are used to prepare hydrogels, membranes, scaffolds, fibers, foams, and sponges, primarily for regenerative medicine. Tissue engineering (TE), currently one of the fastest-growing fields in the life sciences, primarily aims to restore or replace lost or damaged organs and tissues using supports that, combined with cells and biomolecules, generate new tissue. In this sense, the growing interest in the application of biomaterials based on CS and some of its derivatives is justifiable. This review aims to summarize the most important recent advances in developing biomaterials based on CS and its derivatives and to study their synthesis, characterization, and applications in the biomedical field, especially in the TE area.

Keywords: Biotechnology; Chitosan; Derivatives; Polysaccharide; Tissue engineering.

Publication types

  • Review

MeSH terms

  • Biocompatible Materials / chemistry
  • Biocompatible Materials / therapeutic use
  • Chitosan* / chemistry
  • Chitosan* / therapeutic use
  • Regenerative Medicine
  • Tissue Engineering
  • Tissue Scaffolds

Substances

  • Chitosan
  • Biocompatible Materials